Clarissa J. Watts
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Mast cells and histamine, NF-κB Signaling Pathways, Inflammatory Bowel Disease
Most-Cited Works
- A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.(1984)
- → Iκ-B Kinase-2 Inhibitor Blocks Inflammation in Human Airway Smooth Muscle and a Rat Model of Asthma(2005)125 cited
- → A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis(2021)86 cited
- → The Discovery of Phthalazinone-Based Human H1and H3Single-Ligand Antagonists Suitable for Intranasal Administration for the Treatment of Allergic Rhinitis(2011)30 cited
- → 4-Acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a Novel Class of Non-Brain-Penetrant Histamine H3 Receptor Antagonists(2007)24 cited
- → Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis(2017)13 cited
- → Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis(2017)2 cited
- → Abstract OT1-04-01: Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b / randomised phase 2 study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy(2017)